Doggett Betty M, Session-Augustine Nellie, Roig Joseph, Strunk Matthew, Valiyaparambil Shiney, Sarode Ravi, De Simone Nicole
Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.
Therapeutic Apheresis and Cellular Therapy, Terumo BCT, Lakewood, Colorado.
J Clin Apher. 2019 Feb;34(1):21-25. doi: 10.1002/jca.21665. Epub 2018 Nov 2.
Apheresis treatments, which involve the removal of a component of blood, generally require one access and one return line to continuously draw and return blood into the extracorporeal circuit. At our center, we prefer to use peripheral venous access to avoid central line-related complications, especially infection. Motivated by patient-centered care, the single-needle (SN) option for therapeutic plasma exchange (TPE) offered on the Spectra Optia (Terumo BCT, Lakewood, CO) was evaluated. Five patients underwent procedures using both SN and dual-needle (DN) plasma exchange procedures using the Spectra Optia. TPE procedures ran a median of 51 (range:10-102) minutes longer using the SN-TPE option. Inlet flow rates, plasma removal efficiency, and incidence of citrate reactions were similar between SN- and DN-procedures. Patients reported great satisfaction with SN-TPE.